Sponsor or institution

Clinical trials and research at ImmVira Pharma Co. Ltd

As of November 12, 2026, Find a Trial lists 3 clinical trials run by ImmVira Pharma Co. Ltd that are recruiting, at sites in 3 countries (most in United States (2), China (1), Australia (1)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
C5252 injection for intracranial glioma Phase 1/2 Tianjin, Tianjin Municipality Recruiting Nov 21, 2025
Treatment for BCG-Unresponsive High Risk Nonmuscle-Invasive Bladder Cancer Phase 2 Queen Creek, Arizona and 8 other locations Recruiting May 14, 2025
Treatment of advanced solid tumors with T3011 and pembrolizumab Phase 1/2 Gilbert, Arizona and 8 other locations Recruiting May 1, 2020

All recruiting trials (3)

Quick answers

How many clinical trials run by ImmVira Pharma Co. Ltd are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (2 trials), China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.